MediMusic
- Company typePrivate
- Founded2017
- HeadquartersKingston upon Hull, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
MediMusic firmographics
Firmographics- Name
- MediMusic
- Legal name
- MediMusic
- Website
- https://medimusic.co
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
MediMusic industry classification
Industry- Product category
- Digital Therapeutics / Music Therapy Software
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
- akta.pro secondary industry
- Psychiatry & Medication Management Platforms (HLALAEAB)
Keywords
Where MediMusic is headquartered
LocationHeadquarters
- HQ city
- Kingston upon Hull
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
MediMusic business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Infrastructure
Revenue model
- B2B Subscription Service: Monthly per user subscription model for music therapists, providing access to the MediMusic platform, hardware-agnostic solutions including Android & iOS apps, bone conducting headphones, and waterproof headphones for ventilator use
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Monthly per user subscription for B2B music therapists |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
MediMusic product offering
Product offeringCore offering
MediMusic operates an AI-driven digital therapeutic platform that uses artificial intelligence and Music Information Retrieval algorithms to analyze audio features (frequency, loudness, tempo, key) and dispense personalized music as medicine to reduce anxiety, pain, cognitive impairment and mental health conditions. The B2B offering for music therapists includes the MediMusic platform, Android and iOS apps, pre-configured bone conducting headphones, waterproof headphones for ventilator use, full KPI reporting with weekly email summaries, and a monthly per-user subscription model.
Product overview
MediMusic offers a digital therapeutic platform that dispenses music as medicine for anxiety, pain, cognitive impairment, and mental health. The core MediMusic® platform uses AI to analyze music and create personalized playlists based on physiological feedback. The company provides a B2B subscription service for music therapists that includes mobile apps (Android & iOS), pre-configured hardware (bone conducting headphones, waterproof headphones for ventilator use), and weekly email summaries with KPI reporting. The platform is hardware-agnostic and evidence-based, with clinical trials demonstrating effectiveness in reducing anxiety by up to 44%, pain by 29%, and medication use by 24%.
Differentiator
Problem solved
Functional benefit
Products and services
- MediMusic® Platform The core digital therapeutic platform that uses artificial intelligence to mimic the human brain's response to music and dispense it as medicine for pain, anxiety, cognitive impairment and mental health. Provides evidence-based, use-case-specific interventions with full KPI reporting and medication cost savings metrics.
- MediMusic Mobile App Android and iOS mobile application for delivering music therapy, part of the B2B service for Music Therapists, providing access to the AI-driven personalized playlists and platform features.
- B2B Music Therapists Service Monthly per-user subscription service for music therapists, providing hardware-agnostic solutions with pre-configured devices, Android & iOS apps, bone conducting headphones, waterproof headphones for ventilator use, full KPI reporting and weekly email summaries.
Quantifiable outcome
- Reduces anxiety by up to 44%
- +3 more outcomes
Companies that use MediMusic
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
MediMusic technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
MediMusic partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- University of ReadingcoreAcademic research partnership with Dr. Katherine Finlay from Pain Lab & CINN contributing to evidence-based music therapy research.
- Anglia Ruskin UniversitycoreAcademic partnership with Dr. Ming Hsu specializing in Music Therapy Research based in Cambridge.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
MediMusic competitors and assessment
Company assessmentDirect peers
- Big Health: Digital therapeutics company offering evidence-based digital treatments (Sleepio for insomnia, Daylight for anxiety) sold B2B to health systems and employers. Closely comparable to MediMusic as a B2B digital therapeutic targeting anxiety, with NHS and similar health system distribution.
- Akili Interactive: FDA-cleared digital therapeutic company (EndeavorRx) with a focus on evidence-based software as medicine, sold via healthcare providers and payers. Directly comparable to MediMusic as a clinically validated digital therapeutic targeting specific conditions.
- Click Therapeutics: Digital therapeutics company developing prescription software for indications such as depression and migraine, often via pharma partnerships. Comparable as a prescription-grade digital therapeutic with B2B payer/provider distribution.
- Pear Therapeutics: Pioneer in prescription digital therapeutics (reSET, reSET-O, Somryst) for substance use disorder and insomnia before its wind-down. Highly comparable as a regulatory-grade digital therapeutic business model, though now operates as a restructured entity.
Broad incumbents
- Headspace Health: Large-scale mental health digital platform combining mindfulness content with therapy services, sold B2B2C through employers and health plans. Comparable to MediMusic in mental health and B2B distribution, but a much broader, content-led incumbent rather than a music-specific therapeutic.
- Wysa: AI-driven mental health chatbot platform sold to employers and health systems including NHS. Comparable to MediMusic as a B2B digital mental health solution targeting NHS and large employers, though via conversational AI rather than music.
Emerging players
- LUCID (Music Therapy Platform): Music therapy digital platform targeting healthcare settings with curated therapeutic playlists. Closely comparable to MediMusic in the music-as-medicine niche, though a smaller and less clinically evidenced player.
- Limbic: UK-based AI mental health platform providing digital self-referral and triage tools for NHS IAPT services. Comparable to MediMusic as a UK AI mental health B2B platform selling into NHS pathways, though with a different therapeutic modality.
- Wellbeat: Digital therapeutics platform using music and other behavioral interventions to support patient wellness and recovery, sold to hospitals and health systems. Comparable to MediMusic in combining music with clinical outcomes measurement in B2B healthcare.
Regional players
- Zava: UK and Europe-based digital health provider offering online consultations and digital therapeutic services. Comparable to MediMusic as a UK-headquartered digital health B2B/B2C player navigating NHS and European healthcare regulation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
MediMusic social profiles
Digital presenceMediMusic financial estimates
Financial estimateRevenue estimate
Valuation estimate
MediMusic leadership team
Management profileNumber of profiles
Profiles13 records
MediMusic funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MediMusic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MediMusic
What does MediMusic do?
MediMusic operates an AI-driven digital therapeutic platform that uses artificial intelligence and Music Information Retrieval algorithms to analyze audio features (frequency, loudness, tempo, key) and dispense personalized music as medicine to reduce anxiety, pain, cognitive impairment and mental health conditions. The B2B offering for music therapists includes the MediMusic platform, Android and iOS apps, pre-configured bone conducting headphones, waterproof headphones for ventilator use, full KPI reporting with weekly email summaries, and a monthly per-user subscription model.
Is MediMusic a public or private company?
MediMusic is a private company. It is classified as venture growth investor backed and is currently operating.
When was MediMusic founded?
MediMusic was founded in 2017. It employs 11 to 50 people.
Where is MediMusic based?
MediMusic is headquartered in Kingston upon Hull, United Kingdom, in the Europe region.
How does MediMusic make money?
One revenue line is on record: B2B Subscription Service.
Who are MediMusic's main competitors?
Direct peers on record are Big Health, Akili Interactive, Click Therapeutics and Pear Therapeutics. Broad incumbents are Headspace Health and Wysa. Emerging players are LUCID (Music Therapy Platform), Limbic and Wellbeat. Zava is listed as a regional player.
Does MediMusic have an API?
No public API is recorded for MediMusic.
What industry is MediMusic in?
MediMusic's product category is Digital Therapeutics / Music Therapy Software. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621420 and its SIC code is 8000.